Rifaximin and neomycin are typically taken at the same time, both by mouth, for a 14-day course. The standard approach is rifaximin 550 mg three times a day alongside neomycin 500 mg twice a day, though your prescriber may adjust these numbers. The reason both antibiotics are given together rather than separately is that the combination targets methane-producing organisms in the gut far more effectively than either drug alone, and the practical details of how you take them can influence how well the treatment works.
Why Two Antibiotics Instead of One
This dual-antibiotic protocol exists specifically for people who produce excess methane in the small intestine, a condition sometimes called intestinal methanogen overgrowth, or IMO. Methane in the gut is produced not by bacteria but by a separate group of microorganisms called archaea, and archaea are notoriously stubborn. Rifaximin alone knocks out hydrogen-producing bacteria effectively, but methane-producing archaea often survive. Neomycin, an older aminoglycoside antibiotic, has a different mechanism of action and hits the archaea from a different angle.
The landmark study on this combination found that patients who took rifaximin and neomycin together had an 85% clinical response rate, compared with 56% for rifaximin alone and 63% for neomycin alone. The difference was even more striking when researchers measured methane directly: roughly 87% of people on the combination eradicated methane on their breath test, versus only about 28% on rifaximin alone and 33% on neomycin alone.1PubMed. A combination of rifaximin and neomycin is most effective in treating irritable bowel syndrome patients with methane on lactulose breath test That gap is substantial. The combination is not just marginally better; it roughly triples the methane eradication rate compared to either drug on its own.
If your breath test showed elevated methane (generally 10 parts per million or higher), that is almost certainly why your doctor prescribed both. If your test showed only elevated hydrogen without significant methane, rifaximin alone is the more common approach, and neomycin would not usually be added.
How to Time Your Doses
Because rifaximin is taken three times a day and neomycin twice a day, their schedules overlap but do not perfectly align. A practical approach is to take both together in the morning and again in the evening, with a midday dose of rifaximin only. Spacing your doses roughly evenly across waking hours keeps drug levels more consistent in the gut. For most people, that means something like morning, midafternoon, and bedtime for rifaximin, with the morning and bedtime doses also including neomycin.
There is no strict requirement that the two drugs be swallowed at the exact same moment, but there is no reason to separate them either. They do not interact with each other in a way that would reduce either drug’s effectiveness. If you find it easier to take everything at once during overlapping doses, that is fine.
One question that comes up often is whether to take them with food. Rifaximin’s absorption into the bloodstream increases when taken with a meal, but the goal of this treatment is actually to keep rifaximin in the gut, not to absorb it systemically. In practice, most prescribers do not specify food timing for rifaximin in the SIBO or IMO context, and the drug works locally in the intestine regardless. Neomycin is similarly poorly absorbed from the gut. Taking either one with or without food is unlikely to meaningfully change outcomes, so do whatever is most convenient and comfortable for your stomach.
The 14-Day Course and Why Duration Matters
The standard treatment length is 14 days. Some practitioners prescribe 10-day courses, but the 14-day protocol is the one most commonly used and the one studied in the combination trials. Finishing the full course matters. Stopping early because you feel better, or because side effects are mild and you assume it is “enough,” risks leaving a population of archaea that can repopulate quickly.
You should not expect to feel dramatically better during the antibiotic course itself. Some people notice improvement in bloating and constipation within the first week. Others feel about the same, or even slightly worse, while the antibiotics are actively working. A temporary increase in gas or mild abdominal discomfort is not uncommon and does not mean the treatment is failing. The real assessment of whether the course worked happens after you finish, typically with a follow-up breath test.
Side Effects and Safety
Rifaximin is one of the better-tolerated antibiotics available. Because it stays almost entirely within the gut and barely enters the bloodstream, systemic side effects are rare. Studies consistently describe it as having an excellent safety profile with a low rate of adverse events and minimal drug interactions.2PubMed Central. Rifaximin: A Unique Gastrointestinal-Selective Antibiotic for Enteric Diseases The most commonly reported complaints are mild nausea, bloating, and headache, and even those are not much more frequent than placebo in clinical trials.
Neomycin deserves a bit more attention. When given by injection, neomycin can cause serious damage to hearing and kidneys. The oral form used in SIBO and IMO treatment is far safer because very little of it gets absorbed. Ototoxicity from oral neomycin is considered uncommon and is primarily a concern in people with kidney problems or significant inflammation in the gut lining, both of which can increase how much of the drug leaks into the bloodstream.3PubMed. Ototoxicity of oral neomycin and vancomycin For a 14-day oral course in someone with normal kidney function, the risk is very low. That said, if you notice ringing in your ears, muffled hearing, or dizziness during treatment, contact your prescriber promptly. These symptoms are rare but worth knowing about in advance.
Other possible side effects from neomycin include diarrhea and mild nausea. Between the two drugs, most people find the course manageable. The side-effect profile of this combination is considerably milder than what you would experience with many systemic antibiotics.
What to Eat During Treatment
Diet during the antibiotic course is a source of genuine disagreement among practitioners. One school of thought says you should eat normally, including the carbohydrates and fermentable foods you would normally avoid, because feeding the problematic organisms keeps them metabolically active and therefore more vulnerable to antibiotics. The logic is that dormant bacteria and archaea are harder to kill.
The other school of thought recommends continuing a low-fermentation diet during treatment to reduce symptoms like bloating and gas while the antibiotics work. There is no large controlled trial settling this question definitively, and both approaches have reasonable rationale behind them.
A middle-ground approach that many practitioners suggest is to eat a varied diet without going out of your way to restrict fermentable foods, but also without forcing yourself to eat large amounts of things that make you miserable. If your doctor gave you specific dietary instructions for the treatment period, follow those. If they did not, eating your normal diet and including some starches and fiber is a reasonable default.
Biofilm Disruptors as Add-Ons
You may have heard about taking biofilm disruptors alongside your antibiotics. The idea is that gut organisms sometimes protect themselves by forming a sticky matrix called a biofilm, and breaking up that biofilm could let the antibiotics reach their targets more effectively. Some practitioners recommend agents like bismuth, N-acetylcysteine, or various enzyme-based supplements for this purpose.
Research on this strategy is still early. One study found that adding a biofilm-disrupting agent to antibiotic treatment led to larger drops in both hydrogen and methane levels on breath testing compared to antibiotics alone. However, the overall eradication rates did not differ significantly between groups, and neither group fully eradicated methane overgrowth in that trial.4PubMed Central. Biofilm Disruption Enhances Antimicrobial Therapy for Small Intestinal Bacterial Overgrowth and Intestinal Methanogen Overgrowth The signal is promising enough that some clinicians include biofilm disruptors routinely, but the evidence is not yet strong enough to call them essential. If your practitioner recommends one, it is unlikely to cause harm. If they do not mention it, you are not missing a proven game-changer.
After the Course Ends
Once you finish the 14 days, the next question is whether the treatment worked. The most objective way to check is a follow-up lactulose or glucose breath test, usually performed about two to four weeks after finishing antibiotics. This waiting period allows the antibiotics to clear your system so the test reflects your actual gut environment rather than residual drug activity.
A successful outcome on the breath test means methane levels have dropped below the threshold, and ideally your symptoms have improved as well. Keep in mind that symptoms and breath test results do not always move in lockstep. Some people feel significantly better even with a breath test that still shows some elevation. Others normalize their breath test but notice only modest symptom improvement, often because other factors like motility issues or visceral hypersensitivity are contributing to how they feel.
If the first round does not fully eradicate methane, a second course is common. The same combination at the same doses can be repeated, or your prescriber may adjust the approach. Methane overgrowth is particularly stubborn, and needing more than one round of treatment does not mean the protocol has failed. The combination study that reported 87% methane eradication was measuring the result of a single course, so even with the best available treatment, roughly one in eight people will need additional intervention.1PubMed. A combination of rifaximin and neomycin is most effective in treating irritable bowel syndrome patients with methane on lactulose breath test
Preventing Relapse
Eradicating the overgrowth is only half the battle. Without addressing the underlying reason the organisms overgrew in the first place, relapse rates are high. The most common culprit is impaired motility of the small intestine, meaning the normal “sweeping” contractions that move contents through between meals are not working well enough. When material stagnates, organisms have time to multiply.
Many practitioners prescribe a prokinetic agent after the antibiotic course finishes. Prokinetics are drugs or supplements that stimulate those sweeping contractions. Options range from prescription medications like low-dose erythromycin or prucalopride to over-the-counter options. The goal is to keep things moving through the small intestine so that the organisms you just worked to eliminate do not simply come back.
Meal spacing also plays a role. The cleaning contractions of the small intestine are triggered during fasting periods between meals. Constant snacking suppresses them. Leaving four to five hours between meals, and not eating close to bedtime, gives your gut the fasting windows it needs to sweep itself clean. This is not a replacement for prokinetics in severe cases, but it is a free and surprisingly effective habit.
When Metronidazole Is Used Instead of Neomycin
Not every practitioner uses neomycin as the second antibiotic. Metronidazole, often known by the brand name Flagyl, is another option that targets anaerobic organisms and is sometimes paired with rifaximin for methane overgrowth. In one comparative review, metronidazole actually achieved higher rates of breath-test normalization than rifaximin, though rifaximin provided better symptom relief and fewer side effects.5Frontiers in Pharmacology. Antibiotic therapy for small intestinal bacterial overgrowth: a systematic review of comparative efficacy, clinical–test discordance, and pediatric evidence gaps
Metronidazole has a very different side-effect profile from neomycin. It can cause a metallic taste, nausea, and you absolutely cannot drink alcohol while taking it or for at least 48 hours after finishing, because the combination causes severe nausea and vomiting. Some people also experience peripheral neuropathy, tingling or numbness in the hands and feet, with longer courses. Neomycin does not carry those particular risks, which is one reason many SIBO specialists prefer the rifaximin-neomycin combination.
If you have been prescribed metronidazole instead of neomycin, the decision was likely based on your doctor’s clinical experience, drug availability, or your individual health profile. Both combinations are reasonable. The rifaximin-neomycin pairing has the most published data specifically for methane-positive patients, but metronidazole is a well-established alternative.
Drug Interactions and Practical Concerns
Rifaximin has very few meaningful drug interactions because it does not enter the bloodstream in significant amounts.2PubMed Central. Rifaximin: A Unique Gastrointestinal-Selective Antibiotic for Enteric Diseases Neomycin can reduce the absorption of certain other medications taken by mouth, including digoxin and some fat-soluble vitamins, because it affects the intestinal lining slightly. If you take other prescription medications, mention the neomycin to your pharmacist so they can flag any relevant interactions. Separating neomycin from other medications by an hour or two is sometimes recommended as a precaution, though for most common drugs this is not critical during a short course.
One practical issue: cost. Rifaximin is expensive in many countries, particularly in the United States, where a 14-day course can run into the hundreds of dollars even with insurance. Neomycin is comparatively cheap. If your insurance requires prior authorization for rifaximin, your prescriber’s office can usually handle this, but build in time before your intended start date. Some patients obtain rifaximin from international pharmacies at lower cost, though you should discuss this option with your doctor.
Probiotics during treatment are another common question. Most practitioners suggest holding off on probiotics while on antibiotics, since you would essentially be introducing organisms while simultaneously trying to kill them. Reintroducing a probiotic after finishing the course and completing your follow-up breath test is a more logical sequence, though the evidence base for specific probiotic strains in post-SIBO recovery is still thin.
Who Should Not Take This Combination
People with significant kidney impairment need extra caution with oral neomycin. Even though very little is absorbed in a healthy gut, compromised kidneys cannot clear the small amount that does get through, and drug levels can build up over a 14-day course. Your prescriber should check kidney function before starting you on neomycin. The same applies if you have active inflammatory bowel disease with significant ulceration, since a damaged intestinal lining allows more neomycin absorption than normal.3PubMed. Ototoxicity of oral neomycin and vancomycin
Pregnancy and breastfeeding are situations where this combination is generally avoided. Rifaximin’s minimal absorption makes it theoretically lower-risk, but there are not enough human studies to confirm safety during pregnancy. Neomycin carries the same aminoglycoside cautions that apply to its class. If you are pregnant or planning to become pregnant, discuss alternatives with your doctor.
People who are already taking other aminoglycoside antibiotics or drugs known to affect hearing or kidney function should not add neomycin without careful medical oversight. Stacking drugs with overlapping toxicity risks, even when each individual drug’s risk is low, can push the cumulative exposure into a range that matters.